Medgend Icon


Uptravi FDA Approved Drugs

UPTRAVI [SelexipagC26H32N4O4S]
RX
-
0.2mg (oral tablet)
0.4mg (oral tablet)
0.6mg (oral tablet)
0.8mg (oral tablet)
1.2mg (oral tablet)
1.4mg (oral tablet)
1.6mg (oral tablet)
1mg (oral tablet)
Actelion Pharms LtdDec 21, 2015
  • Method of treating pulmonary arterial hypertension comprising administering a crystalline form of selexipag.
  • Method of treating pulmonary arterial hypertension comprising administering a pharmaceutical composition comprising selexipag.
  • Method of treating pulmonary arterial hypertension comprising administering selexipag in combination with the endothelin receptor antagonist macitentan.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.